2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Arthritis, Rheumatoid
8
Melanoma
7
Colitis, Ulcerative
6
Inflammatory Bowel Diseases
5
Crohn Disease
5
Colitis
4
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
3
Urogenital Neoplasms
2
Inflammation
2
Hematologic Neoplasms
2
Graft vs Host Disease
2
Fatigue
2
Depressive Disorder, Major
2
Depression
2
Cachexia
2
Anorexia
2
Vasculitis
1
Takayasu Arteritis
1
Syndrome
1
Stroke
1
Stevens-Johnson Syndrome
1
Spondylitis, Ankylosing
1
Skin Neoplasms
1
Recurrence
1
Rare Diseases
1
Psoriasis
1
Precancerous Conditions
1
Pemphigoid, Benign Mucous Membrane
1
Pancreatic Neoplasms
1
Interventions
Adalimumab
6
Etanercept
3
Anti-Inflammatory Agents, Non-Steroidal
2
tocilizumab
1
secukinumab
1
golimumab
1
Vaccines
1
Tumor Necrosis Factors
1
Tai Ji
1
Sulfasalazine
1
Standard of Care
1
Sodium Chloride
1
Saline Solution
1
Practice Guidelines as Topic
1
Pamidronate
1
Methods
1
Meloxicam
1
Interviews as Topic
1
Infliximab
1
Herpes Zoster Vaccine
1
Exercise
1
Etoricoxib
1
Educational Status
1
Early Intervention, Educational
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Spondylitis, Ankylosing
×
Infliximab
×
Clear all
NCT05379049
2022-05-18
TNF-alpha
University of Sulaimani
Unknown
80 enrolled